90 related articles for article (PubMed ID: 21154311)
1. Malignant transformation to schwannoma in a patient affected by type 1 neurofibromatosis as demonstrated by F-18-FDG-PET/CT.
Bertagna F; Bosio G; Biasiotto G; Fisogni S; Bercich L; Giubbini R
Nucl Med Rev Cent East Eur; 2010; 13(1):15-7. PubMed ID: 21154311
[TBL] [Abstract][Full Text] [Related]
2. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
3. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
5. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Wu ZJ; Zhang YX; Wei H; Jia Q
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
[TBL] [Abstract][Full Text] [Related]
6. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.
Picchio M; Mangili G; Samanes Gajate AM; De Marzi P; Spinapolice EG; Mapelli P; Giovacchini G; Sigismondi C; Viganò R; Sironi S; Messa C
Nucl Med Commun; 2010 Jun; 31(6):506-12. PubMed ID: 20168262
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
[TBL] [Abstract][Full Text] [Related]
8. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O
Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
[TBL] [Abstract][Full Text] [Related]
10. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D
J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347
[TBL] [Abstract][Full Text] [Related]
11. Increased F-18 FDG uptake on positron emission tomography/computed tomography imaging caused by plantar fibromatosis.
Scheler J; Rehani B; Percy T; Pelstring R; Bharija A; Ames D; Mantil J
Clin Nucl Med; 2008 Apr; 33(4):280-1. PubMed ID: 18356670
[TBL] [Abstract][Full Text] [Related]
12. [Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1].
Bensaid B; Giammarile F; Mognetti T; Galoisy-Guibal L; Pinson S; Drouet A; Combemale P
Ann Dermatol Venereol; 2007 Oct; 134(10 Pt 1):735-41. PubMed ID: 17978710
[TBL] [Abstract][Full Text] [Related]
13. Schwannomatosis/neurofibromatosis type 2 associated multiple schwannomas visualized on FDG-PET/CT.
Beylergil V; Haque S; Carver A; Bilsky MH; Carrasquillo JA
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):275-6. PubMed ID: 23582492
[No Abstract] [Full Text] [Related]
14. Benign intrapulmonary schwannoma: aspect on F-18 fluorodeoxyglucose PET/CT.
Gonzalez M; Prior JO; Rotman S; Ris HB; Krueger T
Clin Nucl Med; 2011 Jun; 36(6):465-7. PubMed ID: 21552027
[TBL] [Abstract][Full Text] [Related]
15. The Role of [
Tovmassian D; Abdul Razak M; London K
Int J Surg Oncol; 2016; 2016():6162182. PubMed ID: 28058117
[No Abstract] [Full Text] [Related]
16. An intrathoracic schwannoma case in
Gültekin A; Aydoğmuş Ü; Arifoğlu H; Bir F; Yaylalı O
Hell J Nucl Med; 2020; 23(2):206-208. PubMed ID: 32716413
[TBL] [Abstract][Full Text] [Related]
17. CT, MRI, and PET findings of gastric schwannoma.
Takeda M; Amano Y; Machida T; Kato S; Naito Z; Kumita S
Jpn J Radiol; 2012 Aug; 30(7):602-5. PubMed ID: 22660866
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT findings in recurrent malignant schwannoma.
Halac M; Cnaral F; Sait S; Ylmaz S; Kerim S; Sergülen D; Uslu I
Clin Nucl Med; 2008 Mar; 33(3):172-4. PubMed ID: 18287838
[TBL] [Abstract][Full Text] [Related]
19. Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden.
Özden C; Mautner VF; Farschtschi S; Molwitz I; Ristow I; Bannas P; Well L; Klutmann S; Adam G; Apostolova I; Buchert R
J Neuroimaging; 2024; 34(1):138-144. PubMed ID: 37942683
[TBL] [Abstract][Full Text] [Related]
20. Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1.
Moharir M; London K; Howman-Giles R; North K
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1309-17. PubMed ID: 20179923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]